Skip to main content
Caplight Logo









Pinotbio

Pinotbio

Private
South KoreaHealthcare & Life Scienceshttps://pinotbio.com/

Last Round

VC Round

Oct 27, 2025

Est. Valuation

$79.55M

Total Funding Raised

$31.8M

Company Overview

Pinotbio is a biotechnology company that develops novel anticancer therapeutics and antibody-drug conjugate (ADC) platform technologies.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

antibody-drug conjugateADCanticancer therapeuticsbiotechnology licensingtargeted therapycamptothecindrug discoveryoncology researchlinker technologybiotech platformprecision medicineclinical-stage biotechdrug resistancepayload technologybiopharma partnering

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Pinotbio Comparables

Compare Pinotbio with similar companies based on industry and business-model similarity.

Pinotbio comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Novelty Nobility Inc.
88%
IntoCell Inc
85%
Aimed Bio Inc.
84%

Pinotbio Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundOct 27, 2025
VC RoundApr 21, 2023
StrategicOct 18, 2022
StrategicMar 22, 2021
Series CNov 9, 2020
Series B
Nov 20, 2019

Pinotbio Investors

Notable investors and investment history

Pinotbio investors
InvestorRounds
BNH INVESTMENTVC Round
I-ON Asset ManagementSeries C
KB InvestmentVC Round, Series B
Ulmus InvestmentSeries C
Company K PartnersSeries A, Seed
Stonebridge VenturesSeries B
KB SecuritiesSeries C

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 2, 2025

    Monthly visitors grew 432% MoM, reaching 1.4K.

  • Nov 20, 2019

    $8.44M round with participation from Devsisters Ventures and KB Investment.

Pinotbio Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Pinotbio Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Pinotbio's valuation, stock price, and market status.

Firmographic Details

HeadquartersSouth Korea
Employee Range5
Year Founded2017
Last FundingOct 27, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?